Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of Clostridium perfringens Enterotoxin

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer

2001 • 662 citations

Evaluation of Monoclonal Humanized Anti-HER2 Antibody, Trastuzumab, in Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma With Overexpression of HER2: A Phase II Trial of the Gynecologic Oncology Group

2003 • 588 citations

Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.

2000 • 486 citations

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

2002 • 421 citations

Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.

2003 • 338 citations

Fc receptors are required in passive and active immunity to melanoma

1998 • 322 citations

Identification by cDNA microarray of genes involved in ovarian carcinogenesis.

2000 • 309 citations

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy

2004 • 304 citations

Claudin-4: A new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin

2001 • 296 citations

Coordinately up-regulated genes in ovarian cancer.

2001 • 280 citations

Molecular Cloning and Functional Characterization of the Receptor for Clostridium perfringens Enterotoxin

1997 • 272 citations

Clostridium perfringens Enterotoxin Utilizes Two Structurally Related Membrane Proteins as Functional Receptors in Vivo

1997 • 270 citations

Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.

2001 • 217 citations

Genetic analysis of early- versus late-stage ovarian tumors.

2001 • 201 citations

Differential gene expression between normal and tumor-derived ovarian epithelial cells.

2000 • 165 citations

Induction of Human Papillomavirus-Specific CD4⁺and CD8⁺Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type 16- and 18-Positive Cervical Cancer

1999 • 163 citations

Tumor-host interaction: Analysis of cytokines, growth factors, and tumorinfiltrating lymphocytes in ovarian carcinomas

1997 • 123 citations

Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.

2002 • 97 citations

Association between in Vitro Platinum Resistance in the EDR Assay and Clinical Outcomes for Ovarian Cancer Patients

2002 • 96 citations

Experimental Diarrhoea in Human Volunteers Following Oral Administration of Clostridium perfringens Enterotoxin

1977 • 96 citations

Deletion analysis of the Clostridium perfringens enterotoxin

1997 • 92 citations

Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma

2003 • 88 citations

An overview of Clostridium perfringens enterotoxin

1996 • 87 citations

In vitro induction of tumor-specific human lymphocyte antigen class I–restricted CD8+ cytotoxic T lymphocytes by ovarian tumor antigen–pulsed autologous dendritic cells from patients with advanced ovarian cancer

2000 • 43 citations

Evidence for Clostridium perfringens Enterotoxin (CPE) Inducing a Mitogenic and Cytokine Response In Vitro and a Cytokine Response In Vivo

1999 • 31 citations

Determination of Functional Regions ofClostridium perfringensEnterotoxin Through Deletion Analysis.

1997 • 30 citations

Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes

1996 • 26 citations

Interferon plus chemotherapy for primary treatment of ovarian cancer

2000 • 24 citations

Measurement of biological activities of purified and crude enterotoxin of Clostridium perfringens

1975 • 21 citations

Cited By (0)

Loading...